Chapter 4. Candida Auris, an Emerging Pathogen: Virulence, Current Diagnostic Approaches, and Therapeutic Options


Thayná Ellen de Sousa Alves Ferreira1, Andréa Cristina Barbosa da Silva2, Janaína de Cássia Orlandi Sardi1, Tahyna Duda Deps3, Paula Ribeiro Garcia3Sindy Magri Roque4, Priscila Guimarães Silva Vasconcelos5, Edja Maria Melo de Brito Costa5 and Diego Romario-Silva1,3,*
1Graduate Program in Integrated Dental Sciences, School of Dentistry of the University of Cuiabá, Cuiabá, Brazil
2Department of Pharmacy, State University of Paraiba (UEPB), Campina Grande, PB, Brazil
3Faipe College, Cuiabá, Mato Grosso, Brazil
4School of Pharmaceutical Sciences, State University of Campinas, Campinas, SP, Brazil
5Department of Dentistry, State University of Paraíba, Campina Grande, Paraíba, Brazil

Part of the book: The Book of Fungal Pathogens


Fungal infections have been progressively considered a global threat to human health, added to the limited number of drug classes currently available to treat them. In recent years, atypical pathogens such as Candida auris are being increasingly recovered from human infections. This species is part of the Candida/Clavispora clade and has been claimed to be a “superbug” for its high virulence and resistance to standard antifungals. C. auris was first isolated in 2009, in Japan, from an external ear canal discharge of a female patient and is now a frequent cause of nosocomial outbreaks. The main challenges to control invasive C. auris infections are: difficulties in strain identification, multidrug resistance, virulence factors, and high mortality rates. C. auris strains have a long-term survival on environmental surfaces and are much more resistant than other Candida species. While C. auris has virulence factors as well as Candida albicans (e.g., adhesion, biofilm formation, and production of phospholipases and proteinases), they further developed multidrug resistance to antifungals and a peculiar growth pattern, that is, instead of releasing new cells after budding, they form cell aggregates with high physical resistance. This explains the great adaptability of C. auris cells to host tissues and the environment, including hospital devices such as catheters. Recent research identified several biofilm-related proteins that may be potential therapeutic targets, including enzymes, transcription factors, ribosomal proteins, and transporters. In addition, transporters of the major facilitator superfamily (MFS) and ATP binding cassettes (ABC), which act as efflux pumps, were also reported. These targets are likely related to the intrinsic resistance of C. auris cells to antifungal drugs. To date, an easy method for strain detection, appropriate drug of choice, and therapeutic protocols for treating C. auris infections remain unclear. Thus, in this chapter, we discuss the epidemiology of C. auris, strain detection methods, virulence factors, potential therapeutic targets for the development of new antifungals, as well as the therapeutic options currently available.

Keywords: Candida auris, invasive infection, fungemia


Ahmad, S., and Alfouzan, W. (2021). Candida auris: Epidemiology, Diagnosis, Pathogenesis, Antifungal
Susceptibility, and Infection Control Measures to Combat the Spread of Infections in Healthcare Facilities.
Microorganisms, 9(4), 807.
Ahmad, S., Khan, Z., Al-Sweih, N., Alfouzan, W., and Joseph, L. (2020). Candida auris in various hospitals
across Kuwait and their susceptibility and molecular basis of resistance to antifungal drugs. Mycoses,
63(1), 104–112.
Alfouzan, W., Ahmad, S., Dhar, R., Asadzadeh, M., Almerdasi, N., Abdo, N. M., Joseph, L., de Groot, T.,
Alali, W. Q., Khan, Z., Meis, J. F., and Al-Rashidi, M. R. (2020). Molecular Epidemiology of Candida
auris Outbreak in a Major Secondary-Care Hospital in Kuwait. Journal of Fungi 6 (December): 307.
Alshamrani, M. M., El-Saed, A., Mohammed, A., Alghoribi, M. F., Al Johani, S. M., Cabanalan, H., and
Balkhy, H. H. (2021). Management of Candida auris outbreak in a tertiary-care setting in Saudi Arabia.
Infection control and hospital epidemiology, 42(2), 149–155.
Barantsevich, N. E., Antonina V. Vetokhina, N. I. Ayushinova, O. E. Orlova, and Barantsevich, E. P. (2020).
Candida auris Bloodstream Infections in Russia.” Antibiotics 9 (9): 557.
Casadevall, A., Kontoyiannis, D. P., & Robert, V. (2021). Environmental Candida auris and the Global
Warming Emergence Hypothesis. mBio, 12(2), e00360-21.
Centers for Disease Control and Prevention. Global Emergence of Invasive Infections Caused by the Multidrug resistant Yeast Candida auris [cited 20 April 29]. auris-alert.html.
Centers for Disease Control and Prevention-Recommendations for treatment of Candida auris infections
[cited 22 January 03].
Chakrabarti, A., and Prashant S. (2021). On the Emergence, Spread and Resistance of Candida auris: Host,
Pathogen and Environmental Tipping Points. Journal of Medical Microbiology. Microbiology Society.
Chatterjee, S., Alampalli, S. V., Nageshan, R. K., Chettiar, S. T., Joshi, S., and Tatu, U. S. (2015). Draft genome
of a commonly misdiagnosed multidrug resistant pathogen Candida auris. BMC genomics, 16(1), 686.
Chow, N. A., Gade, L., Tsay, S. V., Forsberg, K., Greenko, J. A., Southwick, K. L., Barrett, P. M., Kerins, J.
L., Lockhart, S. R., Chiller, T. M., Litvintseva, A. P., Adams, E., Barton, K., Beer, K. D., Bentz, M. L.,
Berkow, E. L., Black, S., Bradley, K. K., Brooks, R., Zhu, Y. (2018). Multiple Introductions and
Subsequent Transmission of Multidrug-Resistant Candida auris in the USA: A Molecular
Epidemiological Survey. The Lancet Infectious Diseases 18 (12): 1377-84.
Chow, N. A., Muñoz, J. F., Gade, L., Berkow, E. L., Li, X., Welsh, R. M., Forsberg, K., Lockhart, S. R., Adam,
R., Alanio, A., Alastruey-Izquierdo, A., Althawadi, S., Araúz, A. B., Ben-Ami, R., Bharat, A., Calvo, B.,
Desnos-Ollivier, M., Escandón, P., Gardam, D., Cuomo, C. A. (2020). Tracing the Evolutionary History
and Global Expansion of Candida auris Using Population Genomic Analyses.
MBio11:e03364-19 (March).
Chowdhary, A., Anil Kumar, V., Sharma, C., Prakash, A., Agarwal, K., Babu, R., Dinesh, K. R., Karim, S.,
Singh, S. K., Hagen, F., & Meis, J. F. (2014). Multidrug-Resistant Endemic Clonal Strain of Candida
auris in India. European Journal of Clinical Microbiology and Infectious Diseases 33 (6): 919-26.
Chowdhary, A., Prakash, A., Sharma, C., Kordalewska, M., Kumar, A., Sarma, S., Tarai, B., Singh, A.,
Upadhyaya, G., Upadhyay, S., Yadav, P., Singh, P. K., Khillan, V., Sachdeva, N., Perlin, D. S., and Meis,
J. F. (2018). A multicentre study of antifungal susceptibility patterns among 350 Candida auris isolates
(2009-17) in India: role of the ERG11 and FKS1 genes in azole and echinocandin resistance. The Journal
of antimicrobial chemotherapy, 73(4), 891–899.
Chowdhary, A., Cheshta, S., and Meis, J. F. (2017). Candida auris: A Rapidly Emerging Cause of Hospital Acquired Multidrug-Resistant Fungal Infections Globally. PLoS Pathogens. Public Library of Science.
Chybowska, A. D., Delma, S., Childers, and Farrer, R. A. (2020). Nine Things Genomics Can Tell Us About
Candida auris. Frontiers in Genetics. Frontiers Media S. A. 2020.00351.
Ciurea, C. N., Mare, A. D., Kosovski, I. B., Toma, F., Vintilă, C., and Man, A. (2021). Candida auris and other
phylogenetically related species – a mini-review of the literature. Germs, 11(3), 441–448.
Cortegiani, A., Misseri, G., Fasciana, T., Giammanco, A., Giarratano, A., and Chowdhary, A. (2018).
Epidemiology, Clinical Characteristics, Resistance, and Treatment of Infections by Candida auris.
Journal of Intensive Care. 6, 69.
Di Cosola, M., Cazzolla, A. P., Charitos, I. A., Ballini, A., Inchingolo, F., and Santacroce, L. (2021). Candida
albicans and Oral Carcinogenesis. A Brief Review. Journal of fungi (Basel, Switzerland), 7(6), 476.
Giacobbe, D. R., Magnasco, L., Sepulcri, C., Mikulska, M., Koehler, P., Cornely, O. A., & Bassetti, M. (2021).
Recent advances and future perspectives in the pharmacological treatment of Candida auris infections.
Expert review of clinical pharmacology, 14(10), 1205–1220.
Gonzalez-Lara, María F., and Luis Ostrosky-Zeichner. (2020). “Invasive Candidiasis.” Seminars in Respiratory
and Critical Care Medicine 41 (1): 3-12.
Hata, D. Jane, Romney Humphries, and Shawn R. Lockhart. 2020. “Candida auris: An Emerging Yeast
Pathogen Posing Distinct Challenges for Laboratory Diagnostics, Treatment, and Infection Prevention.”
Archives of Pathology and Laboratory Medicine. College of American Pathologists.
Jeffery-Smith, A., Taori, S. K., Schelenz, S., Jeffery, K., Johnson, E. M., Borman, A., Manuel, R., and Browna,
C. S. (2018). Candida auris: A Review of the Literature. Clinical Microbiology Reviews. American
Society for Microbiology.
Johnson, M. D., Lewis, R. E., Dodds Ashley, E. S., Ostrosky-Zeichner, L., Zaoutis, T., Thompson, G. R.,
Andes, D. R., Walsh, T. J., Pappas, P. G., Cornely, O. A., Perfect, J. R., and Kontoyiannis, D. P. (2020).
Core Recommendations for Antifungal Stewardship: A Statement of the Mycoses Study Group Education
and Research Consortium. The Journal of infectious diseases, 222(Suppl 3), S175–S198.
Kashir J, Yaqinuddin A. (2020). Loop mediated isothermal amplification (LAMP) assays as a rapid diagnostic
for COVID-19. Med Hypotheses. 141:109786.
Kathuria, S., Singh, P. K., Sharma, C., Prakash, A., Masih, A., Kumar, A., Meis, J. F., and Chowdhary, A.
(2015). Multidrug-Resistant Candida auris Misidentified as Candida haemulonii: Characterization by
Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry and DNA Sequencing
and Its Antifungal Susceptibility Profile Variability by Vitek 2, CLSI Broth Microdilution, and Etest
Method. Journal of clinical microbiology, 53(6), 1823–1830.
Khan, Z., Ahmad, S., Al-Sweih, N., Joseph, L., Alfouzan, W., & Asadzadeh, M. (2018). Increasing prevalence,
molecular characterization and antifungal drug susceptibility of serial Candida auris isolates in Kuwait.
PloS one, 13(4), e0195743.
Kim, M., Shin, J. H., Sung, H., Lee, K., Kim, E., Ryoo, N., Lee, J., Jung, S., Park, K. H., Kee, S. J., Kim, S.
H., Shin, M. G., Suh, S. P., & Ryang, D. W. (2009). Candida haemulonii and Closely Related Species at
5 University Hospitals in Korea: Identification, Antifungal Susceptibility, and Clinical Features. Diseases
Society of America 48 (6).
Kim, T. H., Oh, J. K., Kim, H. R., and Lee, M. K. (2016). Identification of Uncommon Candida Species Using
Commercial Identification Systems. Journal of Microbiology and Biotechnology 26 (12): 2206-13.
Kordalewska, M., Lee, A., Park, S., Berrio, I., Chowdhary, A., Zhao, Y., & Perlin, D. S. (2018). Understanding
Echinocandin Resistance in the Emerging Pathogen Candida auris. Antimicrobial agents and
chemotherapy, 62(6), e00238-18.
Kordalewska, M., Zhao, Y., Lockhart, S. R., Chowdhary, A., Berrio, I., and Perlin, D. S. (2017). Rapid and
Accurate Molecular Identification of the Emerging Multidrug-Resistant Pathogen Candida auris. Journal
of Clinical Microbiology 55 (8): 2445-52. 1128/JCM.00630-17.
Kumar, J. A., Eilertson, B., Cadnum, J. L., Whitlow, C. S., Jencson, A. L., Safdar, N., Krein, S. L., Tanner, W.
D., Mayer, J., Samore, M. H., and Donskey, C. J. (2019). Environmental Contamination with Candida
Species in Multiple Hospitals Including a Tertiary Care Hospital with a Candida auris Outbreak.
Pathogens and Immunity 4 (2): 260-70.
Larkin, E., Hager, C., Chandra, J., Mukherjee, P. K., Retuerto, M., Salem, I., Long, L., Isham, N., Kovanda,
L., Borroto-Esoda, K., Wring, S., Angulo, D., and Ghannoum, M. (2017). The Emerging Pathogen
Candida auris: Growth Phenotype, Virulence Factors, Activity of Antifungals, and Effect of SCY-078, a
Novel Glucan Synthesis Inhibitor, on Growth Morphology and Biofilm Formation. Antimicrobial agents
and chemotherapy, 61(5), e02396-16.
Leach, L., Y. Zhu, and S. Chaturvedi. (2018). Development and Validation of a Real-Time PCR Assay For
Rapid Detection of Candida auris from Surveillance Samples. Journal of Clinical Microbiology 56 (2).
Lee, W. G., Shin, J. H., Uh, Y., Kang, M. G., Kim, S. H., Park, K. H., and Jang, H. C. (2011). First three
reported cases of nosocomial fungemia caused by Candida auris. Journal of clinical microbiology, 49(9),
Lockhart, S. R., Etienne, K. A., Vallabhaneni, S., Farooqi, J., Chowdhary, A., Govender, N. P., Colombo, A.
L., Calvo, B., Cuomo, C. A., Desjardins, C. A., Berkow, E. L., Castanheira, M., Magobo, R. E., Jabeen,
K., Asghar, R. J., Meis, J. F., Jackson, B., Chiller, T., and Litvintseva, A. P. (2017). Simultaneous
Emergence of Multidrug-Resistant Candida auris on 3 Continents Confirmed by Whole-Genome
Sequencing and Epidemiological Analyses. Clinical Infectious Diseases 64 (2): 134-40.
Mahmoudi, S., Afshari, S. A. K., Aghaei Gharehbolagh, S., Mirhendi, H., and Makimura, K. (2019). Methods
for identification of Candida auris, the yeast of global public health concern: A review. Journal de
mycologie medicale, 29(2), 174–179.
Martínez-Murcia, A., Navarro, A., Bru, G., Chowdhary, A., Hagen, F., and Meis, J. F. (2018). Internal
validation of GPS™ MONODOSE CanAur dtec-qPCR kit following the UNE/EN ISO/IEC 17025:2005
for detection of the emerging yeast Candida auris. Mycoses, 61(11), 877–884.
McCarty, T. P., White, C. M., and Pappas, P. G. (2021). Candidemia and Invasive Candidiasis. Infectious
Disease Clinics of North America. W. B. Saunders.
Mizusawa, M., Miller, H., Green, R., Lee, R., Durante, M., Perkins, R., Hewitt, C., Simner, P. J., Carroll, K.
C., Hayden, R. T., and Zhang, S. X. (2017). Can Multidrug-Resistant Candida auris Be Reliably Identified
in Clinical Microbiology Laboratories? Journal of Clinical Microbiology 55 (2): 638-40.
Mohr, A., Simon, M., Joha, T., Hanses, F., Salzberger, B., and Hitzenbichler, F. (2020). Epidemiology of
candidemia and impact of infectious disease consultation on survival and care. Infection, 48(2), 275–284.
Mohsin, J., Weerakoon, S., Ahmed, S., Puts, Y., Al Balushi, Z., Meis, J. F., and Al-Hatmi, A. (2020). A Cluster
of Candida auris Blood Stream Infections in a Tertiary Care Hospital in Oman from 2016 to 2019.
Antibiotics (Basel, Switzerland), 9(10), 638.
Mulet Bayona, J. V., Tormo Palop, N., Salvador García, C., Herrero Rodríguez, P., Abril López de Medrano,
V., Ferrer Gómez, C., and Gimeno Cardona, C. (2020). Characteristics and Management of Candidaemia
Episodes in an Established Candida auris Outbreak. Antibiotics (Basel, Switzerland), 9(9), 558.
Muñoz, J. F., Welsh, R. M., Shea, T., Batra, D., Gade, L., Litvintseva, A. P., and Cuomo, C. A. (2021).
Chromosomal Rearrangements and Loss of Subtelomeric Adhesins Linked to Clade-Specific Phenotypes
in Candida auris. Genetics 218 (1). DOI: 10.1093/genetics/iyab029.
Notomi, T., Okayama, H., Masubuchi, H, Yonekawa, T., Watanabe, K., Amino, N., and Hase, T. (2000).
Loop Mediated Isothermal Amplification of DNA. Nucleic Acids Research 28 (12): 63.
Oh, M., Heyl, J., and Babu, B. A. (2020). Candida auris in the Age of Resistance. Cureus, 12(9), e10334.
Osei Sekyere, J. (2018). Candida auris: A Systematic Review and Meta-Analysis of Current Updates on an
Emerging Multidrug-Resistant Pathogen. MicrobiologyOpen 7 (4).
Ostrowsky, B., Greenko, J., Adams, E., Quinn, M., O’Brien, B., Chaturvedi, V., Berkow, E., Vallabhaneni, S.,
Forsberg, K., Chaturvedi, S., Lutterloh, E., Blog, D., Bucher, C., Denis, R. J., Erazo, R., Fernandez, R.,
Southwick, K., and Zhu, Y. C. (2020). Candida auris Isolates Resistant to Three Classes of Antifungal
Medications – New York, 2019, 69(1) 6-9.
Pacilli, M., Kerins, J. L., Clegg, W. J., Walblay, K. A., Adil, H., Kemble, S. K., Xydis, S., McPherson, T. D.,
Lin, M. Y., Hayden, M. K., Froilan, M. C., Soda, E., Tang, A. S., Valley, A., Forsberg, K., Gable, P.,
Moulton-Meissner, H., Sexton, D. J., Jacobs Slifka, K. M., and Black, S. R. (2020). Regional Emergence
of Candida auris in Chicago and Lessons Learned from Intensive Follow-up at 1 Ventilator-Capable
Skilled Nursing Facility. Clinical Infectious Diseases 71 (11): E718-25.
Piedrahita, C. T., Cadnum, J. L., Jencson, A. L., Shaikh, A. A., Ghannoum, M. A., and Donskey, C. J. (2017).
Environmental Surfaces in Healthcare Facilities are a Potential Source for Transmission of Candida auris
and Other Candida Species. Infection control and hospital epidemiology, 38(9), 1107–1109.
Pino-Calm, B., Artola, D. G. M., Gil-Campesino, H., and Alcoba-Flórez, J. (2018). Restriction Fragment
Length Polymorphism of ITS1-ITS2 Region to Identify Candida auris.” Revista Iberoamericana de
Micologia 35 (3): 167-68.
Prakash, A., C. Sharma, A. Singh, P. Kumar Singh, A. Kumar, F. Hagen, N. P. Govender, A. L. Colombo, J.
F. Meis, and A. Chowdhary. (2016). Evidence of Genotypic Diversity among Candida auris Isolates by
Multilocus Sequence Typing, Matrix-Assisted Laser Desorption Ionization Time-of-Flight Mass
Spectrometry and Amplified Fragment Length Polymorphism. Clinical Microbiology and Infection 22
(3): 277.e1-277.e9.
Prestel, C., Anderson, E., Forsberg, K., Lyman, M., Perio, M. A., Kuhar, D., Edwards, K., Rivera, M., Shugart,
A., Walters, M., Dotson, N. Q. (2021). MMWR, Candida auris Outbreak in a COVID-19 Specialty Care
Unit – Florida, July-August 2020. Morbidity and Mortality Weekly Report 70 (2): 56-57.
Rauseo, A. M., Aljorayid, A., Olsen, M. A., Larson, L., Lipsey, K. L., Powderly, W. G., and Spec, A. (2021).
Clinical predictive models of invasive Candida infection: A systematic literature review. Medical
mycology, 59(11), 1053–1067.
Romera, D., Aguilera-Correa, J. J., Gadea, I., Viñuela-Sandoval, L., García-Rodríguez, J., and Esteban, J.
(2019). Candida auris: a comparison between planktonic and biofilm susceptibility to antifungal drugs.
Journal of Medical Microbiology, 68(9), 1353–1358.
Roy, S., Vantipalli, P., Garcha, A., Pokal, M., and Adapa, S. (2021). The Emerging Uncommon Non-albicans
Candida: Candida parapsilosis Peritonitis in a Peritoneal Dialysis Patient. Cureus 13 (8).
Rudramurthy, S. M., Chakrabarti, A., Paul, R. A., Sood, P., Kaur, H., Capoor, M. R., Kindo, A. J., Marak, R.
S. K., Arora, A., Sardana, R., Das, S., Chhina, D., Patel, A., Xess, I., Tarai, B., Singh, P., and Ghosh, A.
(2017). Candida auris Candidaemia in Indian ICUs: Analysis of Risk Factors. Journal of Antimicrobial
Chemotherapy 72 (6): 1794-1801.
Ruiz-Gaitán, A. C., Fernández-Pereira, J., Valentin, E., Tormo-Mas, M. A., Eraso, E., Pemán, J., and de Groot,
P. (2018). Molecular identification of Candida auris by PCR amplification of species-specific GPI
protein-encoding genes. International journal of medical microbiology: IJMM, 308(7), 812–818.
Santana, D. J., & O’Meara, T. R. (2021). Forward and reverse genetic dissection of morphogenesis identifies
filament-competent Candida auris strains. Nature communications, 12(1), 7197.
Sardi, J. C. O., Silva, D. R., Mendes-Giannini, M. J. S., and Rosalen, P. L. (2018). Candid auris: Epidemiology,
Risk Factors, Virulence, Resistance, and Therapeutic Options.” Microbial Pathogenesis. Academic Press.
Satoh, K., Makimura, K., Hasumi, Y., Nishiyama, Y., Uchida, K., and Yamaguchi, H. (2009). Candida auris
sp. nov., a novel ascomycetous yeast isolated from the external ear canal of an inpatient in a Japanese
hospital. Microbiology and immunology, 53(1), 41–44.
Seeniammal, S., Selvakumar, M., and Nirmaladevi, P. (2021). Clinicomycological Study of Vulvovaginal
Candidiasis. Indian Journal of Sexually Transmitted Diseases and AIDS 42 (1): 57-61.
Seneviratne, C. J., Wang, Y., Jin, L., Abiko, Y., and Samaranayake, L. P. (2008). Candida albicans biofilm
formation is associated with increased anti-oxidative capacities. Proteomics 8:2936-2947. 200701097.
Sexton, D. J., Bentz, M. L., Welsh, R. M., and Litvintseva, A. P. (2018). Evaluation of a new T2 Magnetic
Resonance assay for rapid detection of emergent fungal pathogen Candida auris on clinical skin swab
samples. Mycoses, 61(10), 786–790.
Sharp, A., Borman, A. M., Perera, N., Randle, M., Braham, S., Taori, S., Charlett, A., Guy, R., Muller-Pebody,
B., Manuel, R., and Brown, C. S. (2018). Assessing Routine Diagnostic Methods for Detecting Candida
auris in England. Journal of Infection. 77(5) :448-454.
Singh, R., Kaur, M., Chakrabarti, A., Shankarnarayan, S. A., and Rudramurthy, S. M. (2019). Biofilm
formation by Candida auris isolated from colonising sites and candidemia cases.
Mycoses, 62(8), 706–709.
Spivak, E. S., and Hanson, K. (2018). Candida auris: An Emerging Fungal Pathogen. Journal of Clinical
Microbiology 56 (2).
Theill, L., Dudiuk, C., Morales-Lopez, S., Berrio, I., Rodríguez, J. Y., Marin, A., Gamarra, S., & Garcia-Effron,
G. (2018). Single-tube classical PCR for Candida auris and Candida haemulonii identification. Revista
iberoamericana de micologia, 35(2), 110–112.
Vallabhaneni, S., Jackson, B. R., & Chiller, T. M. (2019). Candida auris: An Emerging Antimicrobial
Resistance Threat. Annals of Internal Medicine, 171(6), 432–433.
Villanueva-Lozano, H., Treviño-Rangel, R. de J., González, G. M., Ramírez-Elizondo, M. T., Lara-Medrano,
R., Aleman-Bocanegra, M. C., Guajardo-Lara, C. E., Gaona-Chávez, N., Castilleja-Leal, F., Torre Amione, G., and Martínez-Reséndez, M. F. (2021). Outbreak of Candida auris Infection in a COVID-19
Hospital in Mexico. Clinical Microbiology and Infection.
Elsevier B. V.
Wasi, M., Khandelwal, N. K., Moorhouse, A. J., Nair, R., Vishwakarma, P., Bravo Ruiz, G., Ross, Z. K.,
Lorenz, A., Rudramurthy, S. M., Chakrabarti, A., Lynn, A. M., Mondal, A. K., Gow, N. A. R., and Prasad,
R. (2019). ABC Transporter Genes Show Upregulated Expression in Drug-Resistant Clinical Isolates of
Candida auris: A Genome-Wide Characterization of ATP-Binding Cassette (ABC) Transporter Genes.
Front. Microbiol. 16(10):1445.
Welsh, R. M., Bentz, M. L., Shams, A., Houston, H., Lyons, A., Rose, L. J., and Litvintseva, A. P. (2017).
Survival, Persistence, and Isolation of the Emerging Multidrug-Resistant Pathogenic Yeast Candida auris
on a Plastic Health Care Surface. Journal of clinical microbiology, 55(10), 2996–3005.
Willems, H., Lowes, D. J., Barker, K. S., Palmer, G. E., and Peters, B. M. (2018). Comparative Analysis of the
Capacity of the Candida Species To Elicit Vaginal Immunopathology. Infection and immunity, 86(12),
Yamamoto, M., Alshahni, M. M., Tamura, T., Satoh, K., Iguchi, S., Kikuchi, K., Mimaki, M., and Makimura,
K. (2018). Rapid Detection of Candida auris Based on Loop-Mediated Isothermal Amplification (LAMP).
Journal of clinical microbiology, 56(9), e00591-18.
Zamith-Miranda, D., Heyman, H. M., Cleare, L. G., Couvillion, S. P., Clair, G. C., Bredeweg, E. L., Gacser,
A., Nimrichter, L., Nakayasu, E. S., and Nosanchuk, J. D. (2019). Multi-omics Signature of Candida
auris, an Emerging and Multidrug-Resistant Pathogen. mSystems, 4(4), e00257-19.
DOI: 10.1128/mSystems.00257-19.
Zhang, J., Li, L., Lv, Q., Yan, L., Wang, Y., and Jiang, Y. (2019). The Fungal CYP51s: Their Functions,
Structures, Related Drug Resistance, and Inhibitors. Frontiers in Microbiology, 10(691).
DOI: 10.3389/fmicb.2019.00691.


Publish with Nova Science Publishers

We publish over 800 titles annually by leading researchers from around the world. Submit a Book Proposal Now!